Renasant Bank Abb Vie Inc. Transaction History

Renasant Bank

$138 Million
Q3 2024

A detailed history of Renasant Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Renasant Bank holds 7,118 shares of ABBV stock, worth $1.19 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares

7,118

Previous 7,776 8.46%

Holding current value

$1.19 Million

Previous $1.33 Million 5.4%

% of portfolio

1.02%

Previous 0.98%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$163.84 - $199.33 $107,806 - $131,159	-658 Reduced 8.46%	7,118 $1.41 Million
Q2 2024 Aug 09, 2024	SELL	$154.79 - $180.76 $227,231 - $265,355	-1,468 Reduced 15.88%	7,776 $1.33 Million
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $144,796 - $164,982	-906 Reduced 8.93%	9,244 $1.68 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $146,681 - $165,198	1,066 Added 11.73%	10,150 $1.57 Million
Q3 2023 Nov 01, 2023	BUY	$133.59 - $154.65 $135,460 - $156,815	1,014 Added 12.57%	9,084 $1.35 Million
Q2 2023 Aug 01, 2023	SELL	$132.51 - $164.9 $198,499 - $247,020	-1,498 Reduced 15.66%	8,070 $1.09 Million
Q1 2023 May 05, 2023	SELL	$144.61 - $166.54 $71,581 - $82,437	-495 Reduced 4.92%	9,568 $1.52 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $67,633 - $81,110	-489 Reduced 4.63%	10,063 $1.63 Million
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $192,591 - $220,889	1,435 Added 15.74%	10,552 $1.42 Million
Q2 2022 Aug 03, 2022	BUY	$137.62 - $174.96 $183,997 - $233,921	1,337 Added 17.19%	9,117 $1.4 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $232,416 - $288,363	1,761 Added 29.26%	7,780 $1.26 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $140,733 - $178,068	1,310 Added 27.82%	6,019 $815,000
Q3 2021 Oct 12, 2021	SELL	$106.4 - $120.78 $43,730 - $49,640	-411 Reduced 8.03%	4,709 $508,000
Q2 2021 Jul 19, 2021	BUY	$105.21 - $117.21 $4,208 - $4,688	40 Added 0.79%	5,120 $576,000
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $74,576 - $82,099	-729 Reduced 12.55%	5,080 $549,000
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $467,566 - $631,264	5,809 New	5,809 $622,000

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $295B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renasant Bank, based on Form 13F filings with the SEC.

News

Stay updated on Renasant Bank with notifications on news.

Account